RESMED INC — Director's Dealing 2018

Nov 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-15

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-15	ResMed Common Stock	M	3307	$43.63	Acquired	59112	Direct
2018-11-15	ResMed Common Stock	S	3307	$101.44	Disposed	55805	Direct
2018-11-15	ResMed Common Stock	S	984	$101.44	Disposed	109222	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-15	ResMed Common Stock Options	$43.63	M	3307	Disposed	2020-03-01	ResMed Commmon Stock (3307)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
ResMed Common Stock Options	$101.64	2025-11-14	ResMed Commmon Stock (102975)	102975	Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/3 per year.

F2: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2019, 2020 and 2021.